This website may include forward-looking statements that reflect our current views with respect to, among other things, our operations and financial performance. Forward-looking statements include all statements that are not historical facts. These forward-looking statements relate to matters such as our industry, business strategy, goals and expectations concerning our market position, future operations, margins, profitability, capital expenditures, liquidity and capital resources and other financial and operating information. We use the words “anticipate,” “assume,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “future,” “will,” “seek,” “foreseeable,” the negative version of these words or similar terms and phrases to identify forward-looking statements. The forward-looking statements are based on management’s current expectations and are subject to various risks and uncertainties. We cannot assure you that future developments affecting us will be those that we have anticipated. Actual results may differ materially from these expectations due to changes in global, regional or local economic, business, competitive, market, regulatory and other factors, many of which are beyond our control. We believe that these factors include but are not limited to the following: we face significant and continuing competition, which could adversely affect our operating results; defects, failures or quality issues associated with our products could lead to product recalls or safety alerts, adverse regulatory actions, litigation, including product liability claims, and negative publicity that could erode our competitive advantage and market share and materially adversely affect our reputation, business, financial condition and results of operations; we are subject to various governmental regulations relating to the labeling, marketing, sales and distribution of our products; failure of any of our clinical studies or third-party assessments to demonstrate desired outcomes in proposed endpoints, may result in adverse regulatory actions, reduce physician usage or reduce price, coverage and/or reimbursement for our products, which could have a negative impact on our business performance; cost-containment efforts of our customers, purchasing groups, third-party payers and governmental organizations could adversely affect our sales and profitability; changes in U.S. and international regulations, policies, rules and expanded audit programs of third-party payers regarding billing and reimbursement of our products could reduce reimbursement and collections for our products, adversely affect the demand for our products and negatively impact our global expansion efforts; if we are unable to develop new generations of products and enhancements to existing products, our competitive position may be harmed; the implementation of healthcare reform in the United States may adversely affect our business and financial results; if we are unsuccessful in protecting, maintaining and enforcing our intellectual property, our competitive position could be harmed; pending and future intellectual property litigation could be costly and disruptive and may have an adverse effect on our business, financial condition and results of operations; we may not successfully identify and complete acquisitions or divestitures on favorable terms or achieve anticipated synergies relating to any such transaction, and such transactions could result in unforeseen operating difficulties, regulatory issues and expenditures, require significant management resources and require significant charges or write-downs; we may not realize the expected benefits from our restructuring initiatives and continuous improvement efforts, and they may result in unintended adverse impacts to our business; our failure to comply with program integrity and data privacy and security laws may subject us to penalties and adversely affect our business, financial condition and results of operations; because we depend upon a limited group of suppliers and manufacturers and, in most cases, exclusive suppliers for products essential to our business. We may incur significant product development costs and experience material delivery delays if we lose any significant supplier, which could materially impact the rental and sales of our products; increased prices for, or unavailability of, raw materials or sub-assemblies used in our products could adversely affect our profitability or revenues; if a natural or man-made disaster strikes our or a third-party’s manufacturing facilities, we will be unable to manufacture our products for a substantial amount of time and our sales and profitability will decline; disruption to our distribution operations could adversely affect our business; our international business operations are subject to risks, including risks arising from currency exchange rate fluctuations, which could adversely affect our operating results; failure to comply with the Foreign Corrupt Practices Act of 1977, and other anti-corruption, anti-bribery and anti-money laundering laws associated with our activities outside the United States could subject us to penalties and other adverse consequences; we rely on the performance of our information technology systems, the failure of which could have an adverse effect on our business and performance; our operations are subject to environmental, health and safety laws and regulations that could require us to incur material costs; our ability to use net operating losses to offset future taxable income may be subject to certain limitations; changes in tax laws or exposure to additional income tax liabilities could have a material impact on our financial condition and results of operations; we may not be able to maintain our competitive advantages if we are not able to attract and retain key personnel; adverse changes in general domestic and global economic conditions and instability and disruption of credit markets could adversely affect our operating results, financial condition or liquidity; our substantial indebtedness may have a material adverse effect on our business, financial condition and results of operations including the ability to raise additional capital to fund our operations, limit our ability to react to changes in the economy or our industry, and prevent us from fulfilling our obligations; despite our current level of indebtedness, we may still be able to incur substantially more debt, which could further exacerbate the risks associated with our substantial leverage; we will require a significant amount of cash to service our debt, and our ability to generate cash depends on many factors beyond our control and any failure to meet our debt service obligations could materially adversely affect our business, financial condition and results of operations; our debt instruments restrict our current and future operations, particularly our ability to respond to changes or take certain actions; and our failure to comply with the agreements relating to our outstanding indebtedness, including as a result of events beyond our control, could result in an event of default that could materially adversely affect our business, financial condition and results of operations. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in our filings with the Securities and Exchange Commission (available on www.sec.gov), including our Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, including, among other sections, under the captions “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, our actual results may vary in material respects from those projected in these forward-looking statements. Any forward-looking statement made by us speaks only as of the date made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements and you should not place undue reliance on our forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures, investments or other strategic transactions we may make. We undertake no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by any applicable securities laws.
This Acelity Web site [www.acelity.com] contains information about products which may or may not be available in any particular country and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications and restriction in different countries. Each country has specific laws, regulations and medical practices governing the communication of medical or other information about medical products on the Internet. Nothing herein should be construed as a solicitation or promotion of any product or of an indication of any product which is not authorized by the laws and regulations of the country where the reader resides.
Back to Top
OTHER RULES ABOUT THIS WEB SITE